ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2013

Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.

Sarah Nikiforow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.